Stryker Archives - Page 11 of 17 - Medical Design Sourcing

Stryker launches new Citrelock tendon fixation device system

[Image from Stryker]Stryker (NYSE:SYK) announced today that its trauma & extremities division launched its Citrelock tendon fixation device system.

According to a news release, the Citrelock system offers surgeons a differentiated design through a tendon thread featuring a resorbable technology — Citregen — that has unique chemical and mechanical properties for orthopedic surgical applications.

Citrelock features a controlled and homogeneous resorption process designed to prevent bulk degradation and chronic inflammation while offering strength comparable to cortical bone with a modulus comparable to cancellous bone, Stryker said.

Additionally, Citregen contains citrate, calcium and phosphate molecules that are inherent to the bone anatomy, while the platform includes a material polymer structure designed to mimic the extracellular matrix protein network. Citregen maintains its structural integrity during the healing phase, too, while the implant is rep…

Stryker completes Gauss Surgical acquisition

Stryker (NYSE:SYK) announced today that it acquired Gauss Surgical and its Triton platform for an undisclosed amount.

Menlo Park, California-based Gauss Surgical designed the Triton artificial intelligence-enabled platform for the real-time monitoring of blood loss during surgery. The platform has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention, according to a news release.

Get the full story at our sister site, MassDevice.

Stryker completes Gauss Surgical acquisition

Stryker (NYSE:SYK) announced today that it acquired Gauss Surgical and its Triton platform for an undisclosed amount.

Menlo Park, California-based Gauss Surgical designed the Triton artificial intelligence-enabled platform for the real-time monitoring of blood loss during surgery. The platform has demonstrated improvements in maternal and surgical care through earlier recognition of hemorrhage leading to earlier intervention, according to a news release.

Kalamazoo, Michigan-based Stryker cited studies that suggest that up to 5% of mothers experience a post-partum hemorrhage, which constitutes the leading cause of maternal death globally, and studies suggest that 70% of those are preventable through monitoring platforms like Triton.

“Gauss Surgical’s innovative Triton technology will help fill the void of quantifying blood loss to enable accuracy, early detection of hemorrhage and prevention of maternal morbidity,” Dylan Crotty, Presiden…

Stryker launches new femur retrograde nailing system

Stryker (NYSE:SYK) today announced that it has launched its T2 Alpha femur retrograde nailing system.

Kalamazoo, Mich.-based Stryker designed the system as a data-driven nail design with an advanced locking screw option for axial stability.

Get the full story on our sister site, Medical Design & Outsourcing.

Stryker launches new femur retrograde nailing system

Stryker (NYSE: SYK) today announced that it has launched its T2 Alpha femur retrograde nailing system.

Kalamazoo, Mich.–based Stryker designed the system as a data-driven nail design with an advanced locking screw option for axial stability.

“Stryker has made significant investments in the T2 Alpha Femur Retrograde Nailing System’s instrumentation platform,” Eric Tamweber, VP and general manager of Stryker’s Trauma business, said in a news release. “We are excited to now have a complete lower extremity T2 Alpha Nailing platform available for our surgeon customers.”

The system has a dedicated proximal targeting system to reduce the number of X-ray shots compared to freehand locking. The nails in the system are available in a broad range of sizes and radii of curvature to meet the unique needs of diverse anatomical patient needs.

MedTech 100 roundup: On the rise again

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior.

The shift marks a quick rebound from the -1.2% dip observed in the previous week and the index now sits at its highest week-ending mark ever, having actually hit an all-time best of 119.72 points on Aug. 17.

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry remains well above the marks set around the height of the pandemic, having registered a 29.6% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling an 92.5% asc…

Stryker president Scannell to retire in 2023, CEO Lobo to take on role

Stryker (NYSE:SYK) this week announced that its president and chief operating officer Timothy Scannell will retire on March 31, 2023.

Scannell will transition from his role of president and COO starting October 1, 2021, and will become an advisor to CEO Kevin Lobo. Lobo will become president of the Kalamazoo, Mich.-based company on the same date.

Group presidents J. Andrew Pierce and Spencer Stiles will take on Scannell’s responsibilities, effective October 1, 2021. Pierce, medsurg and neurotechnology group president, and Stiles, orthopedics and spine group president, have served as group presidents since August 2018.

Scannell was appointed president and COO in July 2018. He has been with the company since 1990 and has held numerous leadership roles in sales and marketing since then. He has risen through the company to the role of group president for the medsurg and neurotechnology divisions before becoming company president and COO.

How Stryker is using 3D printing to advance orthopedics

Orthopedic device giant Stryker uses additive manufacturing to make porous geometries that wouldn’t otherwise be possible

DeviceTalks

3D printing, also called additive manufacturing, provides the ability to create new products and designs that are incredibly complex and hard to machine. For 20 years, Stryker has been on a journey to use additive manufacturing specifically to produce complex orthopedic implants. As a result, the company has made great strides when it comes to the way that orthopedic implants are designed and produced.

On a recent episode of our DeviceTalks Tuesdays webinar — sponsored by GE Additive, Foster, and Siemens — Stryker executive Naomi Murray detailed the company’s two-decade additive manufacturing journey. Murray, the company’s director of advanced operations for additive technology, described how innovations utilizing 3D printing make healthcare better.

Go to our sister site Medical Design & Outsourcing to read four takeaw…

How Stryker is using 3D printing to advance orthopedics

Orthopedic device giant Stryker uses additive manufacturing to make porous geometries that wouldn’t otherwise be possible

DeviceTalks

3D printing, also called additive manufacturing, provides the ability to create new products and designs that are incredibly complex and hard to machine. For 20 years, Stryker has been on a journey to use additive manufacturing specifically to produce complex orthopedic implants. As a result, the company has made great strides when it comes to the way that orthopedic implants are designed and produced.

On a recent episode of our DeviceTalks Tuesdays webinar — sponsored by GE Additive, Foster, and Siemens — Stryker executive Naomi Murray detailed the company’s two-decade additive manufacturing journey. Murray, the company’s director of advanced operations for additive technology, described how innovations utilizing 3D printing make healthcare better.

Here are four takeaways on how additive manufacturing is advancing orthope…

Stryker bets that surgeons won’t forget tagged sponges in surgical sites

[Image from Stryker]

Stryker (NYSE:SYK) announced today that it launched its next-generation SurgiCount + safety-sponge system.

Kalamazoo, Mich.-based Stryker designed its next-gen surgical sponge counting technology as its most intelligent version to allow healthcare providers to count and scan sponges and connect to hospitals’ electronic medical records (EMR).

According to a news release, the platform was built on Stryker’s existing technology, with the company designing it to assist with sponge management, which constitutes a safety concern in the operating room as a result of inadequate tools, manual processes and inconsistent practices.

SurgiCount + aims to simplify workflows and streamline processes to create less time spent searching for missing sponges. It includes UHF-RFID tagged sponges, a wireless reader for scanning and counting, an intuitive tablet interface, a workstation…

MedTech 100 roundup: Industry climbs with earnings season in full swing

The medtech industry remains on the upswing as companies see their stocks rising with quarterly earnings providing a boost.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 30) at 118.86 points. Two weeks ago aside — when the index shot up to 145.88 points and quickly tumbled down — this mark would be the index’s all-time best.

The total at the end of last week represents a 2.9% rise from the 115.54-point tally posted by the index at the end of last week (July 23).

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry has registered a 28.7% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling a 91.3% ascent above that point.

The industry’s performance had no cor…

Stryker dips after hours despite Street-beating Q2, raised guidance

Stryker (NYSE:SYK) shares dipped after hours today despite second-quarter results that topped the consensus forecast.

The Kalamazoo, Mich.-based company posted profits of $592 million, or $1.55 per share, on sales of $4.3 billion for the three months ended June 30, 2021, marking a massive bottom-line gain from losses of $83 million this time last year on sales growth of 55.4%.

Adjusted to exclude one-time items, earnings per share were $2.25, 13¢ ahead of Wall Street, where analysts were looking for sales of $18.1 billion.

“We delivered strong financial results in the second quarter,” Stryker chairman & CEO Kevin Lobo said in a news release. “Business momentum continues to build as the pandemic moderates and the integration of Wright Medical is pacing ahead of plan. Our positive outlook is reflected in our raised guidance.”

Stryker said it now expects to log adjusted EPS of between $9.25 and $9.40 per share, with expect…